TLL1
protein-codingtolloid like 1, the group of Astacins
Gene summary
This gene encodes an astacin-like, zinc-dependent, metalloprotease that belongs to the peptidase M12A family. This protease processes procollagen C-propeptides, such as chordin, pro-biglycan and pro-lysyl oxidase. Studies in mice suggest that this gene plays multiple roles in the development of mammalian heart, and is essential for the formation of the interventricular septum. Allelic variants of this gene are associated with atrial septal defect type 6. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~231.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: ClinGen
*TLL1* was first reported in relation to autosomal dominant congenital heart disease in 2009 (Stanczak et al. 2009, PMID: 18830233). Four variants (missense, frameshift) that have been reported in 4 probands in 3 publications (PMID: 18830233, 30293987, 31570783) are included in this curation. There are more variants reported in individuals with CHD in 6 publications, all of which were not scored due to a high minor allele frequency (>0.00001) in gnomAD v.4, being located in the 5’ untranslated region of the gene, the proband having a syndromic phenotype, and/or the proband having an unclear phenotype (PMID: 18830233, 27418595, 28358424, 30293987, 32552793, 34328347). The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by expression data in mouse embryos (PMID: 10331975), protein interaction data (PMID: 19366374, 26744331), and a mouse model showing heart defects (PMID: 10331975). In summary, there is limited evidence supporting the relationship between *TLL1* and autosomal dominant congenital heart disease. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date May 13th, 2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0013123
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0004910
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013123
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013123
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: In addition to managing congenital cardiac malformations, surveillance for (eg, including electrocardiogram) and treatment of accompanying arrhythmias may be effective
Comments: The condition can include arrhthymias as well as frank congenital cardiac malformations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TLL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012464.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 24 | 1 | 26 | ||
| missense | 2 | 1 | 147 | 14 | 2 | 166 |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 3 | 1 | 152 | 38 | 3 | 197 |
Highest pathogenic variant AF is 0.000002052607
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036596.3 | 21 | MANE Select | |
| Ensembl | ENSP00000061240.2 | 21 | MANE Select | |
| RefSeq | NP_001191689.1 | 10 | Standard | |
| Ensembl | ENSP00000421732.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tll1 | Danio rerio | Structure: post-vent region Quality: bifurcated abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Crosslinking of collagen fibrils
- Assembly of collagen fibrils and other multimeric structures
- Collagen biosynthesis and modifying enzymes
- Collagen formation
- Extracellular matrix organization
Biological Process
- skeletal system development
- proteolysis
- extracellular matrix disassembly
- cell differentiation
Molecular Function
- metalloendopeptidase activity
- serine-type endopeptidase activity
- calcium ion binding
- zinc ion binding
Cellular Component
- extracellular region
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000061240
- Coding exons
- 21
- Length
- 230638
- Individuals with no LoFs
- 125725
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 23
- Defined
- 125748
- p
- 0.0000915
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.940 | 484 | 546 | 0.887 | 0.0000289 | 6687 |
| Missense (PolyPhen) | 112 | 171.67 | 0.65242 | 2115 | ||
| Synonymous | -0.942 | 208 | 191 | 1.09 | 0.0000103 | 1818 |
| Loss of Function | 5.44 | 14 | 59.1 | 0.237 | 0.00000347 | 685 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000097 | 0.000088 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Protease which processes procollagen C-propeptides, such as chordin, pro-biglycan and pro-lysyl oxidase. Required for the embryonic development. Predominant protease, which in the development, influences dorsal-ventral patterning and skeletogenesis.;
- Disease
- DISEASE: Atrial septal defect 6 (ASD6) [MIM:613087]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:18830233}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- LoFtool
- 0.461
- RVIS EVS
- -0.93
- RVIS percentile EVS
- 9.72
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.397
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |